These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3292

  • 1. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J, Lemeignan M, Lechat P.
    C R Acad Hebd Seances Acad Sci D; 1975 Nov 24; 281(21):1637-9. PubMed ID: 3292
    [Abstract] [Full Text] [Related]

  • 2. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J, Lemeignan M, Lechat P.
    J Pharmacol Exp Ther; 1977 Dec 24; 203(3):653-63. PubMed ID: 21957
    [Abstract] [Full Text] [Related]

  • 3. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM, van den Bercken J, van der Zalm J.
    Eur J Pharmacol; 1975 Apr 24; 31(2):166-75. PubMed ID: 238851
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J, Lemeignan M, Lechat P.
    Eur J Pharmacol; 1979 Jan 15; 53(3):307-11. PubMed ID: 32061
    [Abstract] [Full Text] [Related]

  • 5. Changes in spontaneous and evoked release of transmitter induced by the crotoxin complex and its component phospholipase A2 at the frog neuromuscular junction.
    Hawgood BJ, Santana de Sa S.
    Neuroscience; 1979 Jan 15; 4(2):293-303. PubMed ID: 34124
    [No Abstract] [Full Text] [Related]

  • 6. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J, del Pozo E, Baños JE, Angaut-Petit D.
    Br J Pharmacol; 1991 Sep 15; 104(1):133-8. PubMed ID: 1686201
    [Abstract] [Full Text] [Related]

  • 7. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H.
    Brain Res; 1978 Sep 22; 153(2):307-18. PubMed ID: 210882
    [Abstract] [Full Text] [Related]

  • 8. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA, Molgó J, Lemeignan M, Lechat P.
    Acta Physiol Pharmacol Latinoam; 1984 Sep 22; 34(4):409-18. PubMed ID: 6242265
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS, Lambert JJ, Marshall IG.
    Br J Pharmacol; 1979 Jan 22; 65(1):53-62. PubMed ID: 216450
    [Abstract] [Full Text] [Related]

  • 10. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD, Volle RL.
    J Pharmacol Exp Ther; 1975 Aug 22; 194(2):362-72. PubMed ID: 239225
    [Abstract] [Full Text] [Related]

  • 11. The action of cobalt ions on neuromuscular transmission in the frog.
    Weakly JN.
    J Physiol; 1973 Nov 22; 234(3):597-612. PubMed ID: 4357999
    [Abstract] [Full Text] [Related]

  • 12. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine.
    Hubbard JI, Wilson DF.
    J Physiol; 1973 Jan 22; 228(2):307-25. PubMed ID: 4346989
    [Abstract] [Full Text] [Related]

  • 13. Changes in the time course of transmitter action produced by procaine.
    Hirst GD, Wood DR.
    Br J Pharmacol; 1971 Jan 22; 41(1):105-12. PubMed ID: 4396126
    [Abstract] [Full Text] [Related]

  • 14. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH, Wilson DF.
    J Pharmacol Exp Ther; 1983 Oct 22; 227(1):260-5. PubMed ID: 6137556
    [Abstract] [Full Text] [Related]

  • 15. Prolonged nerve stimulation causes changes in transmitter release at the frog neuromuscular junction.
    Hinz I, Wernig A.
    J Physiol; 1988 Jul 22; 401():557-65. PubMed ID: 2902219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI.
    Can J Physiol Pharmacol; 1987 May 22; 65(5):747-52. PubMed ID: 2887267
    [Abstract] [Full Text] [Related]

  • 18. The relation between quantum content and facilitation at the neuromuscular junction of the frog.
    Mallart A, Martin AR.
    J Physiol; 1968 Jun 22; 196(3):593-604. PubMed ID: 4298821
    [Abstract] [Full Text] [Related]

  • 19. Differential sensitivity to Mg(2+)-and tubocurarine-block of frog neuromuscular junctions in summer and winter.
    Wernig A, Dorlöchter M, Palazis P.
    Neurosci Lett; 1996 Mar 22; 207(1):41-4. PubMed ID: 8710205
    [Abstract] [Full Text] [Related]

  • 20. Estimation of the dissociation constant of d-tubocurarine and the receptor for endogenous acetylcholine.
    Bowen JM.
    J Pharmacol Exp Ther; 1972 Nov 22; 183(2):333-40. PubMed ID: 4343415
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.